Joseph Thome is a managing director and senior research analyst on Cowen and Company’s biotechnology team. Dr. Thome was selected as a “Rising Star in Equity Research” by Business Insider in 2021 and the Cowen biotechnology team has consistently been among the top-ranked teams in the Greenwich Survey.
Prior to joining Cowen in March 2016, Dr. Thome was an NIH pre-doctoral research fellow at Columbia University, studying the compartmentalization and maintenance of the human T cell immune response from infancy into adulthood. His research has been published in several prestigious journals including Cell and Nature Medicine.
Dr. Thome received a BA with high honors in chemistry and biochemistry from Oberlin College and a Ph.D. in microbiology and immunology from Columbia University, where he was granted the Dean’s Award for Excellence in Research. HCBiopharma
Get In Touch
Start a conversation with Joseph Thome
Explore related thought leadership, reports, coverage and insights for Joseph Thome.